Verve Therapeutics
Barry Ticho MD, PhD, serves as the Chief Medical Officer at Stoke Therapeutics and is an Advisory Board Member at Sania Therapeutics, as well as a Scientific Advisory Board Member at Cardior Pharmaceuticals. Barry Ticho is also a Founder and Board Member at Verve Therapeutics and previously held the position of Head of Development for Cardiovascular and Metabolic Diseases at Moderna Therapeutics. Barry Ticho's educational background includes a BA in Biology from Haverford College and medical training at Harvard Medical School.
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.